MS vs CPAY
By Alex · Tickerpine
Morgan Stanley vs Corpay, Inc., side by side — the numbers that matter, in plain English. No “winner” hype; you decide.
| Metric | MS | CPAY |
|---|---|---|
| Price | $190.65 | $462.22 |
| Market cap | $297.99B | $29.57B |
| P/E ratio | 15.1 | 25.4 |
| ROE | 18.04% | 32.21% |
| Profit margin | 25.63% | 23.73% |
| Revenue growth | 10.80% | 17.90% |
| Dividend yield | 2.41% | 0.00% |
| Beta | 1.22 | 0.92 |
Green = the more favorable figure for that metric (lower P/E, higher ROE, margin, growth and yield). Not a recommendation.
MS vs CPAY in plain English
- MS is the bigger company — about 10.1× the market cap of CPAY.
- MS is cheaper on earnings (P/E 15.1 vs 25.4).
- CPAY earns a higher return on equity (32% vs 18%).
- CPAY is growing revenue faster (18% vs 11%).
- MS pays a dividend (2.41%) while the other effectively doesn't.
How would $1,000 have done in each?
MS return calculator
See what $1,000 in Morgan Stanley would be worth today.
CPAY return calculator
See what $1,000 in Corpay, Inc. would be worth today.
Figures from public market data, may be delayed. Comparison is informational only — not investment advice.